Chimerix Inc (CMRX)
0.9529
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.9548
0.00 (0.00%)
After-Hours: 20:00
Chimerix Cash from Investing (Quarterly): 28.07M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.07M |
| September 30, 2023 | 11.87M |
| June 30, 2023 | 18.52M |
| March 31, 2023 | 12.14M |
| December 31, 2022 | -228.40M |
| September 30, 2022 | 238.27M |
| June 30, 2022 | 6.70M |
| March 31, 2022 | 53.47M |
| December 31, 2021 | 23.19M |
| September 30, 2021 | 15.46M |
| June 30, 2021 | 5.971M |
| March 31, 2021 | -88.72M |
| December 31, 2020 | 17.56M |
| September 30, 2020 | -7.332M |
| June 30, 2020 | 36.24M |
| March 31, 2020 | 18.24M |
| December 31, 2019 | 1.02M |
| September 30, 2019 | 39.70M |
| June 30, 2019 | 15.74M |
| March 31, 2019 | -45.83M |
| December 31, 2018 | 66.04M |
| September 30, 2018 | -2.206M |
| June 30, 2018 | 19.32M |
| March 31, 2018 | 21.94M |
| Date | Value |
|---|---|
| December 31, 2017 | 12.55M |
| September 30, 2017 | 5.323M |
| June 30, 2017 | 14.92M |
| March 31, 2017 | -16.37M |
| December 31, 2016 | 11.79M |
| September 30, 2016 | 29.82M |
| June 30, 2016 | 17.09M |
| March 31, 2016 | 35.37M |
| December 31, 2015 | 9.313M |
| September 30, 2015 | -58.11M |
| June 30, 2015 | -65.98M |
| March 31, 2015 | -54.72M |
| December 31, 2014 | -44.13M |
| September 30, 2014 | -33.94M |
| June 30, 2014 | -18.89M |
| March 31, 2014 | -62.74M |
| December 31, 2013 | 0.931M |
| September 30, 2013 | 6.495M |
| June 30, 2013 | 3.191M |
| March 31, 2013 | -1.155M |
| December 31, 2012 | -9.912M |
| September 30, 2012 | -0.08M |
| June 30, 2012 | -0.035M |
| March 31, 2012 | 5.888M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-228.40M
Minimum
Dec 2022
238.27M
Maximum
Sep 2022
11.46M
Average
15.74M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| UFP Technologies Inc | -2.756M |
| Dentsply Sirona Inc | -43.00M |
| Arbutus Biopharma Corp | 22.22M |
| Pacira BioSciences Inc | 8.374M |
| Karyopharm Therapeutics Inc | 26.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.59M |
| Cash from Financing (Quarterly) | 0.062M |
| Free Cash Flow | -69.18M |
| Free Cash Flow Per Share (Quarterly) | -0.1641 |
| Free Cash Flow to Equity (Quarterly) | -14.59M |
| Free Cash Flow to Firm (Quarterly) | -14.59M |
| Free Cash Flow Yield | -81.93% |